# A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women

> **NCT00152295** · PHASE2 · COMPLETED · sponsor: **Abbott** · enrollment: 18 (actual)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Asoprisnil/Premarin

## Key facts

- **NCT ID:** NCT00152295
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2001-12
- **Final completion:** 2001-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152295, "A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00152295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*